NASDAQ:HCSG - Nasdaq - US4219061086 - Common Stock
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky.
HCSG stock results show that Healthcare Services Group met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare Services Group (NASDAQ:HCSG) just reported results for the second qu...
These seven companies are facing significant headwinds, making them prime stocks to sell before they potentially go under.
Cigna looks like a shining star as many health insurance companies fare poorly in 2024 due to higher Medicare Advantage (MA) expenses
HCSG stock results show that Healthcare Services Group beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Healthcare Services (HCSG) reported Q4 results: Non-GAAP EPS beats by $0.04, revenue misses by $1.4M. Adjusted EBITDA increased by 14.2% over Q4 2022.
Cigna's Medicare Advantage unit attracts interest, valued at over $3 billion, as HCSC and Elevance consider potential acquisition opportunities.
With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal.
Read about the Q3 2023 results of healthcare service company HCSG, with non-GAAP EPS of $0.17 and revenue of $424M.
Although you can chase the hottest ideas of the moment, bargain hunters should consider these undervalued stocks under $20.